British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...
UK's Haleon reported annual profit in line with market expectations on Thursday, as the Sensodyne toothpaste and Advil ...
Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...
HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.
Sign up here to find us in your inbox every Wednesday, along with monthly travel and beauty guides, and the latest stories ...
Sensodyne-maker Haleon’s annual profits rose in line with expectations last year as it got a boost in demand for its oral ...
Boss Mark Read (pictured) said that although revenues were hit by weaker client discretionary spending, growth of 2% was seen ...
Haleon, which focuses on over-the-counter medicines, oral health, and vitamins, minerals and supplements, generated £1.9bn in ...
MORE than a dozen FTSE companies dumped their figures on the City yesterday to comply with rules to report within three ...
Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ETCompany ParticipantsJo Russell - Head-Investor RelationsBrian McNamara ...
For 2025 Haleon expects organic revenue growth of 4% to 6%, organic operating profit growth ahead of organic revenue growth with both likely to be weighted towards the second half of the year. The ...
Consumer healthcare giant Haleon reiterated its full-year outlook on Thursday, after posting improved full-year sales and profits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results